Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022)

Evaxion A (EVAX) reported Cash from Financing Activities of -$300000.0 for Q2 2022, down 101.19% on a YoY basis from $25.2 million in Q2 2021, and down 103.88% quarter-over-quarter from $7.7 million in Q1 2022.

Evaxion A (EVAX) Cash from Financing Activities (2020 - 2022) Analysis & Trends

Evaxion A has reported Cash from Financing Activities for 3 years, with the latest figure at -$300000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Cash from Financing Activities fell 101.19% year-over-year to -$300000.0; the trailing twelve-month figure through Jun 2022 stood at $57.8 million (up 1.64% YoY), and the FY2025 full-year result was $22.4 million, up 70.69% from the prior year.
  • Cash from Financing Activities for Q2 2022 stood at -$300000.0, down from $7.7 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $25.3 million in Q1 2021, with the low at -$300000.0 in Q2 2022.
  • Historically, Cash from Financing Activities has averaged $11.2 million across 3 years, with a median of $7.1 million in 2020.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities jumped 140388.89% — and 2022, when it plunged 101.19%.
  • Evaxion A's Cash from Financing Activities stood at $6.4 million in 2020, then soared by 290.38% to $25.2 million in 2021, then sank by 101.19% to -$300000.0 in 2022.
  • The last three Cash from Financing Activities figures came in at -$300000.0 (Q2 2022), $7.7 million (Q1 2022), and $25.2 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn -802.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 -300,000.00
Jun 30, 2022 -300,000.00
Mar 31, 2022 7.74 Mn
Mar 31, 2022 7.74 Mn
Sep 30, 2021 25.15 Mn
Sep 30, 2021 25.15 Mn
Jun 30, 2021 25.22 Mn
Jun 30, 2021 25.22 Mn
Mar 31, 2021 25.25 Mn
Mar 31, 2021 25.25 Mn
Sep 30, 2020 6.44 Mn
Sep 30, 2020 6.44 Mn
Jun 30, 2020 -36,000.00
Jun 30, 2020 -36,000.00
Mar 31, 2020 -18,000.00
Mar 31, 2020 -18,000.00